Uwe Peukert

Directeur Technique/Scientifique/R&D chez NewVac LLC

Profil

Dr. Uwe Peukert is SVP-Strategic Investment Initiative at Torrey Pines Investment, Inc. He has over 25 years hands-on experience in the medical field of which he was practicing medicine and medical science for 14 years and he is in his 12th year working within the field of biotechnology and pharmaceutical industry.
Uwe has joined the management team of Torrey Pines Investment, Inc. as a€?SVP Strategic Investment Initiativesa€? and he continues to be the CEO and President of PharmaSearchEval LLC.
He is a highly experienced medical doctor (Board eligible in US for Pediatrics, Neonatology/Intensive Care and Pediatric Cardiology, Board certified in Germany), with a deep scientific foundation (PhD in Pharmacology/Toxicology of Medical School Hannover, Germany).
During the past decade he established a highly successful record of accomplishment in several business development roles serving large and mid-size pharmaceutical companies.
Previously, Dr. Peukert was Senior Director at Onyx Pharmaceuticals where he was responsible for the search and evaluation function within the business development department.
He initiated and lead the technical evaluation/DD resulting in the acquisition of Proteolix Inc (2009, South San Francisco) and the out-licensing of Japanese rights to Carfilzomib to Ono Pharmaceuticals (2010, Osaka/Japan).

Postes actifs de Uwe Peukert

Sociétés	Poste	Début
NewVac LLC	Directeur Technique/Scientifique/R&D	-

Anciens postes connus de Uwe Peukert

Sociétés	Poste	Fin
Onyx Pharmaceuticals, Inc.	Corporate Officer/Principal	-
Torrey Pines Investment, Inc.	Private Equity Investor	-